Five glycomics projects have been awarded funding to develop new tools, diagnostics and therapeutics to improve health for Canadians.
Étiquette : le cancer
Glycoengineering provides insight into new cancer immunotherapies
By remodelling sugars on cell surfaces, GlycoNet researchers aim to map the linkages between proteins in the immune system and sugars on cancer cells
Top 10 stories from GlycoNet in 2022
A spotlight on some of the most exciting glycomics innovations from the past year.
GlycoNet start-up GlyCa Biosciences Inc. and Huron Innovation Inc. partner to improve prostate cancer detection
This partnership will launch the clinical trial of a new blood test to perfect early detection and diagnosis of clinically significant prostate cancer.
Tiny antibodies could help treat an aggressive type of breast cancer
GlycoNet researchers have developed specialized nanobodies that could enable the immune system to fight triple-negative breast cancer more effectively.
French 
English